Abstract: The invention relates to immunogenic compositions comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), conjugated to a carrier protein, and optionally including an aluminum-based adjuvant. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.

Abstract: A cockpit internal anti-sabotage system (CIASS) without compromising the cockpit security and the present anti-hijacking procedure and protocol, wherein a single cockpit crew alone in the cockpit cannot deny bonafide entry of other cockpit crew or cabin crew in an attempt to commit suicide or sabotage the aircraft, the system comprises a manual door lock system and an automated door lock system wherein both the systems comprising a mechanical system or a non-mechanical system or combination of both.

Abstract: The present invention relates to a bio-assisted treatment of wastewater containing sulphide, phenols and hydrocarbons. Further, the present invention relates to a process for eliminating sulphide and other sulphur compounds including, but not limited to, mercaptans, disulfides, PAHs, phenols and hydrocarbons.

Abstract: The invention relates to immunogenic compositions comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), conjugated to a carrier protein, and optionally including an aluminum-based adjuvant. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.

Abstract: Automated systems and methods for implementing and managing the submission, quote, proposal and binding stages (i.e., placement process) for securing insurance coverage.

Abstract: The present invention provides a process for preparation of halo substituted benzoic acid compound of Formula (1) and intermediates thereof.

Abstract: The present invention provides a process for preparation of halo substituted benzoic acid compound of Formula (1) and intermediates thereof.

Abstract: The present invention deals with employing Heteroatoms namely Nitrogen, Sulphur intrinsic embedded carbon nanotubes (H-CNT) as multifunctional additive for preparing lead acid battery electrodes to substitute the expander chemicals namely, Vanisperse, Dinel Fibre, Barium sulphate and carbon black. Further the invention provides H-CNT in-situ produced from Crude oil or its products.

Abstract: The present invention relates to a bio-assisted treatment of wastewater containing sulphide, phenols and hydrocarbons. Further, the present invention relates to a process for eliminating sulphide and other sulphur compounds including, but not limited to, mercaptans, disulfides, PAHs, phenols and hydrocarbons.

Abstract: Automated systems and methods for implementing and managing the submission, quote, proposal and binding stages (i.e., placement process) for securing insurance coverage.

Abstract: The invention relates to immunogenic polysaccharide-protein conjugates comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), and a carrier protein, wherein the CP is selected from the group consisting of serotypes Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX, and wherein the CP has a sialic acid level of greater than about 60%. The invention also relates to methods of making the conjugates and immunogenic compositions comprising the conjugates. The invention also relates to immunogenic compositions comprising polysaccharide-protein conjugates, wherein the conjugates comprise a CP from GBS serotype IV and at least one additional serotype. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.

Abstract: The present invention relates to an apparatus and method for bio-assisted treatment of spent caustic obtained from hydrocarbon and gas processing installations. The present invention also relates to method for recovery of caustic and recovery of sulfur from spent caustic. According to present invention, the sulfide removal is about 96% and the sulphur formation and deposition on the electrode lies in range of 72±8%.

Abstract: A method for joint replacement is provided. A representation of a first bone is created, and a representation of a second bone is created. Bone preparation for implanting a first implant on the first bone is planned. The first bone to receive the first implant is prepared by manipulating a surgical tool to sculpt the first bone. Bone preparation for implanting a second implant on the second bone after preparing the first bone is planned. The second bone to receive the second implant is prepared by manipulating the surgical tool to sculpt the second bone.

Abstract: The invention relates to immunogenic polysaccharide-protein conjugates comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), and a carrier protein, wherein the CP is selected from the group consisting of serotypes Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX, and wherein the CP has a sialic acid level of greater than about 60%. The invention also relates to methods of making the conjugates and immunogenic compositions comprising the conjugates. The invention also relates to immunogenic compositions comprising polysaccharide-protein conjugates, wherein the conjugates comprise a CP from GBS serotype IV and at least one additional serotype. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.

Abstract: The present invention deals with employing Heteroatoms namely Nitrogen, Sulphur intrinsic embedded carbon nanotubes (H-CNT) as multifunctional additive for preparing lead acid battery electrodes to substitute the expander chemicals namely, Vanisperse, Dinel Fibre, Barium sulphate and carbon black. Further the invention provides H-CNT in-situ produced from Crude oil or its products.

Abstract: Automated systems and methods for implementing and managing the submission, quote, proposal and binding stages (i.e., placement process) for securing insurance coverage.

Abstract: The invention relates to immunogenic compositions comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), conjugated to a carrier protein, and optionally including an aluminum-based adjuvant. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive immunotherapy.

Abstract: Automated systems and methods for implementing and managing the submission, quote, proposal and binding stages (i.e., placement process) for securing insurance coverage.

Abstract: A cockpit internal anti-sabotage system (CIASS) without compromising the cockpit security and the present anti-hijacking procedure and protocol, wherein a single cockpit crew alone in the cockpit cannot deny bonafide entry of other cockpit crew or cabin crew in an attempt to commit suicide or sabotage the aircraft, the system comprises a manual door lock system and an automated door lock system wherein both the systems comprising a mechanical system or a non-mechanical system or combination of both.

Abstract: This invention provides a buffered solution comprising acadesine, as well as compositions, formulations and kits containing said solution. The solution, compositions, formulation, and kits can be used to prevent morbidity/mortality in a patient or to treat an ischaemic condition, a condition regulated by adenosine, or a condition associated with reduced blood flow to a tissue in a patient.